Volume 13; Issue 11

Main
The Lancet Oncology
Volume 13; Issue 11

The Lancet Oncology

Volume 13; Issue 11

1

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study

David Olmos, Daniel Brewer, Jeremy Clark, Daniel C Danila, Chris Parker, Gerhardt Attard, Martin Fleisher, Alison HM Reid, Elena Castro, Shahneen K Sandhu, Lorraine Barwell, Nikhil Babu Oommen, Suzann

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 361 KB

english, 2012

2

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study

Robert W Ross, Matthew D Galsky, Howard I Scher, Jay Magidson, Karl Wassmann, Gwo-Shu Mary Lee, Leah Katz, Sumit K Subudhi, Aseem Anand, Martin Fleisher, Philip W Kantoff, William K Oh

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 423 KB

english, 2012

3

Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial

FOxTROT Collaborative Group

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 197 KB

english, 2012

4

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial

Yong Sang Hong, Young Suk Park, Ho Yeong Lim, Jeeyun Lee, Tae Won Kim, Kyu-pyo Kim, Sun Young Kim, Ji Yeon Baek, Jee Hyun Kim, Keun-Wook Lee, Ik-Joo Chung, Sang-Hee Cho, Kyung Hee Lee, Sang Joon Shin,

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 200 KB

english, 2012

5

Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012

Sheila Payne, Noreen Chan, Andrew Davies, Edward Poon, Stephen Connor, Cynthia Goh

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 246 KB

english, 2012

6

Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?

Hashim Uddin Ahmed, Manit Arya, Alex Freeman, Mark Emberton

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 588 KB

english, 2012

7

Preoperative chemotherapy for colon cancer is getting closer

Andrés Cervantes

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 150 KB

english, 2012

8

Conditional survival of patients with metastatic renal-cell carcinoma

Maxine Sun, Quoc-Dien Trinh, Pierre I Karakiewicz

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 37 KB

english, 2012

9

Predicting the future of advanced prostate cancer

Karina Dalsgaard Sørensen

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 175 KB

english, 2012

10

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

Siow Ming Lee, Iftekhar Khan, Sunil Upadhyay, Conrad Lewanski, Stephen Falk, Geraldine Skailes, Ernie Marshall, Penella J Woll, Matthew Hatton, Rohit Lal, Richard Jones, Elizabeth Toy, David Chao, Gar

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 314 KB

english, 2012

11

Treatment of breast cancer during pregnancy

Ketan Gajjar, Pierre L Martin-Hirsch, Francis L Martin

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 37 KB

english, 2012

12

S-1 in colorectal cancer: a new standard of care?

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 171 KB

english, 2012

13

Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012

Geoffrey Ku, Iain BeeHuat Tan, Thomas Yau, Narikazu Boku, Sudsawat Laohavinij, Ann-Lii Cheng, Yoon-Koo Kang, Gilberto de Lima Lopes Jr

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 128 KB

english, 2012

14

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 406 KB

english, 2012

15

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

Georgina V Long, Uwe Trefzer, Michael A Davies, Richard F Kefford, Paolo A Ascierto, Paul B Chapman, Igor Puzanov, Axel Hauschild, Caroline Robert, Alain Algazi, Laurent Mortier, Hussein Tawbi, Tabea

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 259 KB

english, 2012

16

Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012

Edmund Chiong, Miah Hiang Tay, Min Han Tan, Santosh Kumar, Hong Gee Sim, Bin Tean Teh, Rainy Umbas, Noan Minh Chau

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 122 KB

english, 2012

17

Who should receive EGFR tyrosine-kinase inhibitors?

Helena A Yu, Gregory J Riely

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 120 KB

english, 2012

18

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

Hagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, Selina Luger, Parameswaran Venugopal, Lori Maness, Meir Wetzler, Steven Coutre, Wendy Stock, David Claxton, Stuart L Goldberg, Martha Arellano

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 186 KB

english, 2012

19

Cancer charities force government to rethink welfare reforms

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 85 KB

english, 2012

20

Genetic link to male breast cancer

Talha Khan Burki

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 85 KB

english, 2012

21

Aggressive breast cancer genetically similar to ovarian cancer

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 83 KB

english, 2012

22

Swiss vote “no” to comprehensive smoking ban

Talha Khan Burki

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 83 KB

english, 2012

23

HIPEC: standard of care or an experimental approach?

Serge Evrard, Camille Mazière, Grégoire Désolneux

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 41 KB

english, 2012

24

Improving outcomes for elderly patients with AML

Nigel H Russell

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 180 KB

english, 2012

25

BRAF and MEK inhibitors in BRAF-mutant melanoma

Sharan Prakash Sharma

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 126 KB

english, 2012

26

Can Big Pharma join forces to expedite drug development?

Mary Beth Nierengarten

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 120 KB

english, 2012

27

UK cancer death rates to decrease by 2030

Frances Whinder

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 120 KB

english, 2012

28

Active surveillance beats surgery in low-risk prostate cancer

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 126 KB

english, 2012

29

Menarche, menopause, and breast cancer risk

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 84 KB

english, 2012

30

MDM2 inhibition in liposarcoma: a step in the right direction

Anastasia Constantinidou, Seth M Pollack, Robin L Jones

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 149 KB

english, 2012

31

The limitations of imaging response criteria

Ankit I Mehta, John H Sampson

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 310 KB

english, 2012

32

Treatment options in elderly patients with glioblastoma

Aman Sharma, Daya Nand Sharma, Parmod Kumar Julka, Goura Kishor Rath

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 43 KB

english, 2012

33

Tackling cancer burden in the Middle East: Qatar as an example

Robert Brown, Karen Kerr, Abdelali Haoudi, Ara Darzi

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 169 KB

english, 2012

34

2012 ESMO congress

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 95 KB

english, 2012

35

SIOP Annual Congress

David Collingridge

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 227 KB

english, 2012

36

Tobacco control in the Middle East

Talha Khan Burki

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 332 KB

english, 2012

37

Big pharma looks to ancient China for new cures

Ted Alcorn, Yadan Ouyang

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 177 KB

english, 2012

38

Treatment options in elderly patients with glioblastoma – Authors' reply

Annika Malmström, Roger Stupp, Monika Hegi, Johan Rosell, Roger Henriksson

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 43 KB

english, 2012

39

Fibulin-3 as a biomarker for mesothelioma

Talha Khan Burki

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 78 KB

english, 2012

40

New vaccine for cervical cancer shows promise

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 78 KB

english, 2012

41

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

Isabelle Ray-Coquard, Jean-Yves Blay, Antoine Italiano, Axel Le Cesne, Nicolas Penel, Jianguo Zhi, Florian Heil, Ruediger Rueger, Bradford Graves, Meichun Ding, David Geho, Steven A Middleton, Lyubomi

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 225 KB

english, 2012

42

Modern cancer management and research in the Middle East

Nagi S El Saghir

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 45 KB

english, 2012

43

Carcinogenicity assessments: WHO decides?

The Lancet Oncology

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

44

Lighting up the big screen

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 162 KB

english, 2012

45

Dallas reprised

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 106 KB

english, 2012

46

Rad Art: A Journey Through Radiation Treatment

David M Mastrianni

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 406 KB

english, 2012

47

Cubop City Blues

Frances Whinder

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 405 KB

english, 2012

48

When David lost his voice

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 318 KB

english, 2012

49

Voices from the front: November

David M Mastrianni

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 318 KB

english, 2012

50

Correction to Lancet Oncol 2012; 13: 983, 986

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 30 KB

english, 2012

51

Correction to Lancet Oncol 2012; 13: 1028

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 30 KB

english, 2012

52

Correction to Lancet Oncol 2012; 13: e468

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 30 KB

english, 2012